Companies: 10,795·Total market cap: $144.5T

Bicycle Therapeutics plc

Bicycle Therapeutics plc

BCYCNASDAQHealthcare● Active

$4.20

+$0.00(+0.00%)

Market Cap$291457047

P/E Ratio—

52W High$9.36

52W Low$4.075

Avg Volume434K

Open$4.23

Beta1.54

Net Income Financials Revenue

Bicycle Therapeutics plc (BCYC) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

BCYC · net income · updated Jun 8, 2026

Core profitability metrics

BCYC · net income · margin · TTM · CAGR

Net income was −$219.0M for FY2025 (fiscal year ending 2025-12-31), down 29.5% year-over-year. Net profit margin was -301.7%.

FY2025 Net Income−$219.0M▼ -29.5% YoY

Trailing 12M (TTM)−$219.0Mtrailing 4 quarters sum

Net Profit Margin-301.7%−$219.0M ÷ $72.6M

YoY Change-29.5%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %

▸ FMP /income-statement · Annual · BCYC net income history · BCYC profit margin

Annual net income data

BCYC · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025Loss−$219.0M▼ 29.5%-301.7%$72.6M

FY2024Loss−$169.0M▲ +6.4%-479.2%$35.3M

FY2023Loss−$180.7M▼ 60.3%-669.7%$27.0M

FY2022Loss−$112.7M▼ 68.7%-779.4%$14.5M

FY2021Loss−$66.8M▼ 31.0%-571.3%$11.7M

Net income vs peers (Healthcare)

BCYC vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

#1

Bicycle Therapeutics plcYOU

BCYC

−$219.0M-29.5%-301.7%

Loss

Johnson & Johnson

$26.80B+90.6%28.5%

Eli Lilly and Company

$20.64B+94.9%31.7%

UnitedHealth Group Incorporated

$12.06B-16.3%2.7%

$4.23B-1.2%6.9%

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Bicycle Therapeutics plc (BCYC) reported net income of −$219.0M for FY2025 (fiscal year ending 2025-12-31), down 29.5% year-over-year. The net profit margin was -301.7% — meaning the company kept $-3.02 of every dollar of revenue as profit.

Bicycle Therapeutics plc has not yet achieved annual profitability based on available data (10 fiscal years). The company has reported net losses across all available periods.

Bicycle Therapeutics plc's net profit margin was -301.7% for FY2025, based on the latest annual results.

Investors sometimes search for "Bicycle Therapeutics plc net worth" — the company's market capitalization is a separate figure from BCYC net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

BCYC net income · 4 questions

Bicycle Therapeutics plc is not currently profitable on an annual basis. The company reported a net loss of $219.0M for FY2025.

is BCYC profitabledoes BCYC make a profitBCYC profitabilityBCYC profitable company

▸ Source: FMP /income-statement · GAAP · Bicycle Therapeutics plc · Bicycle Therapeutics plc SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026